Felipe A. Vieira Braga

Felipe A. Vieira Braga

Auto-generated profile, based on publicly available information

Felipe A. Vieira Braga

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam University Medical Centers, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Nature Medicine
Verified
Journal Article
Open access
PDF file
FBFelipe A. Vieira Braga
Felipe A. Vieira Braga
GKGozde Kar
Gozde Kar
MBMarijn Berg
Marijn Berg
OCOrestes A. Carpaij
Orestes A. Carpaij
KPKrzysztof Polanski
Krzysztof Polanski
STSarah A. Teichmann
Sarah A. Teichmann
Human lungs enable efficient gas exchange and form an interface with the environment, which depends on mucosal immunity for protection against infectious agents. Tightly controlled interactions between structural and immune cells are required to maintain lung homeostasis. Here, we use single-cell transcriptomics to chart the cellular landscape of upper and lower airways and lung parenchyma in healthy lungs, and lower airways in asthmatic lungs. We report location-dependent airway epithelial cell states and a novel subset of tissue-resident memory T cells. In the lower airways of patients with asthma, mucous cell hyperplasia is shown to stem from a novel mucous ciliated cell state, as well as goblet cell hyperplasia. We report the presence of pathogenic effector type 2 helper T cells (TH2) in asthmatic lungs and find evidence for type 2 cytokines in maintaining the altered epithelial cell states. Unbiased analysis of cell–cell interactions identifies a shift from airway structural cell communication in healthy lungs to a TH2-dominated interactome in asthmatic lungs.

10 August 2018 in Science
Verified
Journal Article
Closed access
PDF file
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
FBFelipe A. Vieira Braga
Felipe A. Vieira Braga
MTMaxine G. B. Tran
Maxine G. B. Tran
BSBenjamin J. Stewart
Benjamin J. Stewart
SBSam Behjati
Sam Behjati
Pediatric and adult kidney tumors differ: Understanding tumor origins and the similarities and differences between organ-specific cancers is important for determining treatment options. Young et al. generated more than 72,000 single-cell transcriptomes from healthy and cancerous human kidneys. From these data, they determined that Wilms tumor, a pediatric kidney cancer, originates from aberrant fetal cells, whereas adult kidney cancers are likely derived from a specific subtype of proximal convoluted tubular cell. Science , this issue p. 594

27 September 2019 in Science
Verified
Journal Article
Closed access
PDF file
BSBenjamin J. Stewart
Benjamin J. Stewart
JFJohn R. Ferdinand
John R. Ferdinand
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
KLKevin W. Loudon
Kevin W. Loudon
MCMenna R. Clatworthy
Menna R. Clatworthy
Immune landscape of the human kidney: Single-cell RNA sequencing has begun to shed light on the full cellular diversity of specific organs. However, these studies rarely examine organ-specific immune cells. Stewart et al. sequenced healthy adult and fetal kidney samples at a single-cell level to define the heterogeneity in epithelial, myeloid, and lymphoid cells. From this dataset, they identified zonation of cells, with relevance to disease and the varied perturbations that occur in different tumor settings. This profiling of the human kidney generates a comprehensive census of existing cell populations that will help inform the diagnosis and treatment of kidney-related diseases. Science , this issue p. 1461

2 June 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SNSanne M. van Neerven
Sanne M. van Neerven
NGNina E. de Groot
Nina E. de Groot
LNLisanne E. Nijman
Lisanne E. Nijman
BSBrendon P. Scicluna
Brendon P. Scicluna
MDMilou S. van Driel
Milou S. van Driel
LVLouis Vermeulen
Louis Vermeulen

3 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLars Custers
Lars Custers
EKEleonora Khabirova
Eleonora Khabirova
TCTim H. H. Coorens
Tim H. H. Coorens
TOThomas R. W. Oliver
Thomas R. W. Oliver
CCCamilla Calandrini
Camilla Calandrini
JDJarno Drost
Jarno Drost
Malignant rhabdoid tumour (MRT) is an often lethal childhood cancer that, like many paediatric tumours, is thought to arise from aberrant fetal development. The embryonic root and differentiation pathways underpinning MRT are not firmly established. Here, we study the origin of MRT by combining phylogenetic analyses and single-cell mRNA studies in patient-derived organoids. Comparison of somatic mutations shared between cancer and surrounding normal tissues places MRT in a lineage with neural crest-derived Schwann cells. Single-cell mRNA readouts of MRT differentiation, which we examine by reverting the genetic driver mutation underpinning MRT,SMARCB1loss, suggest that cells are blocked en route to differentiating into mesenchyme. Quantitative transcriptional predictions indicate that combined HDAC and mTOR inhibition mimic MRT differentiation, which we confirm experimentally. Our study defines the developmental block of MRT and reveals potential differentiation therapies.

27 April 2019
Verified
Book Chapter
Closed access
PDF file
FBFelipe A. Vieira Braga
Felipe A. Vieira Braga
RMRicardo J. Miragaia
Ricardo J. Miragaia